LA MARCA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.203
AS - Asia 13.523
EU - Europa 10.626
SA - Sud America 2.166
Continente sconosciuto - Info sul continente non disponibili 463
AF - Africa 337
OC - Oceania 85
Totale 63.403
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.380
SG - Singapore 4.367
GB - Regno Unito 2.846
CN - Cina 2.831
IT - Italia 2.320
HK - Hong Kong 1.969
BR - Brasile 1.660
VN - Vietnam 1.536
SE - Svezia 1.129
DE - Germania 885
FI - Finlandia 790
BD - Bangladesh 775
UA - Ucraina 596
RU - Federazione Russa 520
CA - Canada 447
TR - Turchia 428
FR - Francia 409
IN - India 303
KR - Corea 256
BG - Bulgaria 244
ID - Indonesia 181
AR - Argentina 180
NL - Olanda 179
JP - Giappone 151
MX - Messico 142
ES - Italia 137
IQ - Iraq 112
ZA - Sudafrica 90
EC - Ecuador 78
PL - Polonia 76
CO - Colombia 71
PK - Pakistan 70
AU - Australia 65
RO - Romania 64
PH - Filippine 62
AE - Emirati Arabi Uniti 60
IR - Iran 52
CR - Costa Rica 51
MY - Malesia 51
CL - Cile 50
IE - Irlanda 50
VE - Venezuela 50
UZ - Uzbekistan 45
DZ - Algeria 42
MA - Marocco 42
BE - Belgio 39
LT - Lituania 39
DK - Danimarca 38
JM - Giamaica 38
CH - Svizzera 37
AT - Austria 34
CZ - Repubblica Ceca 34
KE - Kenya 34
EG - Egitto 31
TW - Taiwan 31
PY - Paraguay 29
SA - Arabia Saudita 28
TH - Thailandia 28
HN - Honduras 26
JO - Giordania 24
NP - Nepal 24
IL - Israele 22
TN - Tunisia 22
AL - Albania 20
SC - Seychelles 20
DO - Repubblica Dominicana 17
GT - Guatemala 17
NZ - Nuova Zelanda 17
PE - Perù 17
AZ - Azerbaigian 16
BO - Bolivia 16
KZ - Kazakistan 16
NI - Nicaragua 16
HR - Croazia 15
NG - Nigeria 15
NO - Norvegia 14
HU - Ungheria 12
LV - Lettonia 12
MD - Moldavia 12
PS - Palestinian Territory 12
TT - Trinidad e Tobago 12
GR - Grecia 11
PR - Porto Rico 11
PT - Portogallo 11
UY - Uruguay 11
EE - Estonia 10
SV - El Salvador 10
PA - Panama 9
ET - Etiopia 8
OM - Oman 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
BA - Bosnia-Erzegovina 7
EU - Europa 7
GH - Ghana 7
QA - Qatar 7
BB - Barbados 6
KW - Kuwait 6
LB - Libano 6
RS - Serbia 6
Totale 62.833
Salva come PNG Salva come JPEG
Città #
Ashburn 4.609
Fairfield 3.903
Singapore 2.723
Santa Clara 2.499
Hong Kong 1.918
Woodbridge 1.887
Southend 1.737
Houston 1.602
Seattle 1.495
Cambridge 1.308
San Jose 1.269
Wilmington 1.179
Chandler 1.125
Jacksonville 911
Council Bluffs 831
Ann Arbor 759
Dearborn 681
Helsinki 679
Nyköping 675
Beijing 639
London 633
Hefei 590
Los Angeles 522
Ho Chi Minh City 494
New York 406
Chicago 402
Modena 399
The Dalles 380
Hanoi 340
San Diego 299
Milan 259
Princeton 240
Dallas 239
Sofia 235
Boardman 228
Seoul 212
Izmir 207
Lauterbourg 194
Eugene 193
Moscow 185
Buffalo 182
São Paulo 177
Columbus 170
Rome 144
Shanghai 139
Atlanta 121
Bremen 119
Phoenix 118
Salt Lake City 114
Jakarta 112
Tokyo 106
Toronto 94
Munich 87
Guangzhou 86
Bologna 84
Frankfurt am Main 78
Denver 77
San Francisco 77
Orem 76
Da Nang 74
Montreal 73
Tampa 72
Redwood City 68
Brooklyn 67
Amsterdam 65
Redondo Beach 65
Haiphong 64
Naples 63
Vancouver 59
Warsaw 54
Saint Augustine 53
Philadelphia 50
Rio de Janeiro 50
Washington 46
Chennai 45
Elk Grove Village 45
Baghdad 44
Dublin 43
Johannesburg 43
Mexico City 42
Winnipeg 42
Stockholm 41
Falls Church 40
Norwalk 40
Boston 39
Tashkent 39
Biên Hòa 38
North Bergen 38
San José 38
Fremont 37
Miano 37
Norfolk 37
Turin 36
Honolulu 35
Newark 35
Kilburn 34
Melbourne 34
Nanjing 34
Charlotte 33
Florence 32
Totale 43.171
Salva come PNG Salva come JPEG
Nome #
The complex relationship between female age and embryo euploidy 1.052
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial 673
Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period 583
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). 561
Chronic endometritis in recurrent implantation failure: Use of prednisone and IVF outcome 551
Anti-Mullerian hormone (AMH): what do we still need to know? 499
The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study 469
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling 458
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice 454
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach 452
MATER protein as substrate of PKCepsilon in human cumulus cells. 431
Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium. 416
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period 386
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria 384
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles 383
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 382
From a circle to a sphere: the ultrasound imaging of ovarian follicle with 2D and 3D technology 378
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period 369
Pregnant woman infected by Coronavirus disease (COVID-19) and calcifications of the fetal bowel and gallbladder 365
A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos 363
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? 361
Human ovarian tissue cryopreservation: effect of sucrose concentration on morphological features after thawing 360
FSHR polymorphism p.N680S mediates different responses to FSH in vitro 360
Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium 359
The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH 358
How Much Does AMH Really Vary in Normal Women? 354
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology 352
Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium 345
Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol 344
Adnexal torsion during pregnancy after oocyte in vitro maturation and intracytoplasmic sperminjection cycle 340
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 337
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles 335
Nitric Oxide concentration in endometrial washing throughout the menstrual cycle 333
Elevated levels of nitrous dioxide are associated with lower AMH levels: A real-world analysis 333
Vitamin D and ovarian reserve: making clinical decisions 330
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization 329
A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles 327
Periodontal disease and nitric oxide levels in low risk women with preterm labor 323
The physiology and clinical utility of anti-Mullerian hormone in women 322
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome 322
Primary ovarian insufficiency: autoimmune causes. 321
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 320
Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study 320
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 317
The management of vaginal agenesis: report of 104 cases 317
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction 316
Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study 313
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation 307
Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? 305
The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro 305
The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro 305
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count 305
Seminal plasma total antioxidant capacity and semen parameters in patients with varicocele 304
Hypothalamo-pituitary-adrenal axis and adrenal function before and after ovariectomy in premenopausal women 303
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history 302
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI) 302
Anti-Mullerian hormone concentrations in maternal serum during pregnancy 300
Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea 298
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 298
The use of ovarian reserve markers in IVF clinical practice: a national consensus 296
Adrenal adenocarcinoma and empty sella syndrome in a 37-year-old woman 295
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 294
Gonadotrophins modulate cell death-related genes expression in human endometrium 294
Structural sperm and aneuploidies studies in a case of spermatogenesis recovery after the use of androgenic anabolic steroids 292
Metformin treatment of PCOS during adolescence and the reproductive period 290
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 290
Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause 290
Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in PCOS patients 289
The negative impact of most relevant infections on fertility and Assisted Reproduction Technology 285
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation 284
The ovarian follicular pool and reproductive outcome in women. 284
Utero-vaginal anastomosis in the treatment of cervical atresia 284
Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: An individual patient data meta-analysis 282
Rectus abdominis muscle endometriosis: Case report and review of the literature 281
Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome 279
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study 278
Reply: The two sides of the individualization of controlled ovarian stimulation 276
Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes 274
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata 274
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 273
Serum anti-Mullerian hormone throughout the human menstrual cycle 272
How to personalize ovarian stimulation in clinical practice 271
8th World Congress of Gynecological Endocrinology 267
Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy 265
Rectovaginal fistula repair using fascia graft of autologous abdominal muscles 264
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age 262
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 262
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia 261
Anti-Müllerian hormone: clairvoyance or crystal clear? 260
Soluble L-selectin levels during controlled ovarian hyperstimulation 260
How adenomyosis changes throughout pregnancy: A retrospective cohort study 260
Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply 258
The journey from the old to the new AMH assay: how to avoid getting lost in the values 258
Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance 258
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women 258
Thyroid function in early pregnancy II: Paradoxical growth hormone response to thyrotropin-releasing hormone 256
Gonadotropins in the Management of Couple Infertility: Toward the Rational Use of an Empirical Therapy 255
Hormonal and ultrasound markers of ovarian function in a woman with a balanced 1;11 translocation 255
Ultrastructural and DNA fragmentation analyses in swim-up selected human sperm 254
Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome 254
Totale 33.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 247.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 247.805
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.015 0 0 0 160 84 175 345 216 415 356 872 392
2022/20233.625 454 416 349 293 473 434 82 308 414 39 174 189
2023/20243.007 95 153 122 270 479 180 510 456 68 95 131 448
2024/20258.209 260 89 107 581 1.510 1.099 434 449 1.158 519 786 1.217
2025/202618.625 1.057 530 1.581 2.000 2.208 1.427 2.410 1.109 1.884 1.583 1.490 1.346
2026/20277.406 1.546 1.606 1.714 2.540 0 0 0 0 0 0 0 0
Totale 63.403